Cargando…
Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749863/ https://www.ncbi.nlm.nih.gov/pubmed/34933012 http://dx.doi.org/10.1016/j.jpeds.2021.12.026 |
| _version_ | 1784850123791007744 |
|---|---|
| author | Clarke, Rebecca Ioannou, Adam |
| author_facet | Clarke, Rebecca Ioannou, Adam |
| author_sort | Clarke, Rebecca |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9749863 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97498632022-12-14 Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar? Clarke, Rebecca Ioannou, Adam J Pediatr Letter to the Editor Elsevier Inc. 2022-04 2021-12-18 /pmc/articles/PMC9749863/ /pubmed/34933012 http://dx.doi.org/10.1016/j.jpeds.2021.12.026 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Clarke, Rebecca Ioannou, Adam Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar? |
| title | Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar? |
| title_full | Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar? |
| title_fullStr | Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar? |
| title_full_unstemmed | Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar? |
| title_short | Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar? |
| title_sort | should t2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749863/ https://www.ncbi.nlm.nih.gov/pubmed/34933012 http://dx.doi.org/10.1016/j.jpeds.2021.12.026 |
| work_keys_str_mv | AT clarkerebecca shouldt2mappingbeusedincasesofrecurrentmyocarditistodifferentiatebetweentheacuteinflammationandchronicscar AT ioannouadam shouldt2mappingbeusedincasesofrecurrentmyocarditistodifferentiatebetweentheacuteinflammationandchronicscar |